M/S Bhagwati Medical Hall & Anr. v. Central Drugs Standard Control Organization & Ors
- Citation
- 2024 INSC 1048; [2024] 12 S.C.R. 2102
- Court
- Supreme Court of India
- Bench
- Justice Vikram Nath, Justice Prasanna Bhalachandra Varale
- Decided
- 18 Dec 2024
- Case number
- No. 14735/2024
- Sections
- 26A, 22(1), 22
Not a certified copy. Text extracted from the judgment PDF published by the Supreme Court of India. Verify against the certified copy before relying on it. Source: Supreme Court of India, via the Indian Supreme Court Judgments dataset by Dattam Labs (CC-BY-4.0). Retrieved 17 Nov 2026, 12:24 am. Original source ↗
Preview: first 50% of the document.
[2024] 12 S.C.R. 2102 : 2024 INSC 1048 M/s Bhagwati Medical Hall & Anr.
v.
Central Drugs Standard Control Organization & Ors.
(Civil Appeal No(s). 14735-14736 of 2024)
19 December 2024 [Vikram Nath and Prasanna B. Varale, JJ.] Issue for Consideration Whether District Magistrate’s order prohibiting sale of 'aromatic tincture of cardamom' on the ground of it containing a high level of alcohol was correct and in accordance with the statutory framework of Drugs & Cosmetics Act, 1940.
Headnotes† Drugs and Cosmetics Act, 1940 (D&C Act) – District Magistrate (DM), Agra issued orders prohibiting sale of “alcohol mixed tinctures” – Drug Inspector acted on said orders and prevented Appellants from selling “aromatic tincture of cardamom” on the ground that it was an alcohol mixed tincture – Appellants, being licensed distributor of “aromatic tincture of cardamom” under D&C Act objected to such prohibition and challenged said actions of Respondents before High Court – Dismissed; review petition also dismissed by High Court – Appellants approached Supreme Court:
Held: The Court held that under D&C Act, power to ban or categorize any drug as prohibited article in public interest vests solely with the Central Government under Section 26A of the D&C Act – Such legislative scheme of centralised decision-making is deliberate to prevent fragmentation of drug regulatory regime in India and to ensure uniformity and avoid inconsistent local measures. [Paras 7-9] On facts, the Court found no notification issued by Central Government prohibiting / restricting trade of “aromatic tincture of cardamom” – It also referred to the list of prohibited drugs issued by the Ministry of Health and Family Welfare through their gazette notifications that was attached as Annexure P17 with the special leave petition. [Para 10] [2024] 12 S.C.R. 2103M/s Bhagwati Medical Hall & Anr. v. Central Drugs Standard Control Organization & Ors.
Thus, the directions issued by the DM was held to be against the legislative scheme of D&C Act. – Respondents’ reliance on Section 22(1)(d) of D&C Act to justify their actions was rejected by the Court for the reason that the said provision was procedural in nature and was limited to inspecting, sampling, seizing non-compliant drugs, and in all enforcing the existing statutory framework and could not be a substitute for Central Government’s prerogative under Section 26A of D&C Act. [Para 11] The Court found that High Court failed to appreciate the distinction between general regulatory authority and the special, centralized power to prohibit drugs under D&C Act; that also adversely impacted the rights of the Appellants in this case who were a duly licensed trader. [Para 13] List of Acts Drugs & Cosmetics Act, 1940; Constitution of India.
List of Keywords Prohibited article; Aromatic Tincture of cardamom; Alcohol mixed tincture; Restriction; Sale; Ban; prohibition; Public interest; Medicine; Section 26A and Section 22 of Drugs & Cosmetics Act; Central government; Local authorities.
Case Arising From CIVIL APPELLATE JURISDICTION: Civil Appeal No(s). 14735- 14736 of 2024 From the Judgment and Order dated 12.07.2022 and 22.09.2022 of the High Court of Judicature at Allahabad in WRITC No. 13134 of 2022 and CMRA No. 355 of 2022 respectively Appearances for Parties Nikhil Goel, Sr. Adv., Ms. Parul Shukla, Ms. Shubhangi Pandey, Saday Mondol, Advs. for the Appellants.
K M Nataraj, A.S.G., Samar Vijay Singh, Ms. Sabarni Som, Fateh Singh, Keshav Mittal, Dr. Sukhdev Sharma, Venkatesh Rajput, Santosh Kumar, Sharath Nambiar, Vinayak Sharma, B K Satija, Annirudha Sharma- II, Amrish Kumar Sharma, Gurmeet Singh Makker, Advs. for the Respondents.
2104 [2024] 12 S.C.R.Supreme Court Reports Judgment / Order of the Supreme Court Order
1. Leave granted.
2. These appeals, by the Appellants, challenge the correctness of the orders dated 12.07.2022 and 22.09.2022 passed by the High Court of Judicature at Allahabad in Writ C No.13134 of 2022 and Civil Misc. Review Application No.355 of 2022, respectively. By the impugned orders, the High Court dismissed the writ petition as well as the review petition preferred by the Appellants, thereby upholding the actions taken by the Respondent authorities restricting the sale of a medicinal preparation known as “aromatic tincture of cardamom” at the Appellants’ medical shops.
3. The factual background giving rise to the present appeals are as follows:
3.1. The Appellants are proprietors of medical firms/shops engaged for several decades in the wholesale and retail sale of drugs and medicines at Agra, Uttar Pradesh. They hold valid and subsisting licenses under the Drugs & Cosmetics Act, 1940 (hereinafter, “D&C Act, 1940”) and the rules framed thereunder, permitting them to sell, stock, and distribute various drugs, including a herbal medicinal preparation commonly referred to as “aromatic tincture of cardamom.”
3.2. The said tincture, as stated by the Appellants, is a nonprescription, licensed medicine recognized under the D&C Act, 1940. It is used for treating mild ailments such as indigestion, flatulence, stomach pain, nausea, and vomiting. The tincture is manufactured by licensed manufacturers who are approved by the Indian Government, and the Appellants procure their supplies from such recognized sources, including the British Pharmacopoeia-approved suppliers.
3.3. The Appellants submit that, despite the lawful nature of their business, the Respondent authorities—comprising officers from the Drug Control and Excise Departments of the State— subjected their shops to repeated inspections, abrupt closures, and harassment.
[2024] 12 S.C.R. 2105M/s Bhagwati Medical Hall & Anr. v. Central Drugs Standard Control Organization & Ors.
3.4. On earlier occasions, the Appellants approached the High Court of Judicature at Allahabad, which, by an order dated 27.09.2021, directed that the State authorities shall not interfere with the running of the Appellants’ business except in accordance with law.
3.5. Further grievances arose when the District Magistrate, Agra, issued orders on 28.02.2022 constituting a joint team to curb the sale of “alcohol mixed tinctures,” and the Drug Inspector thereafter, on 11.04.2022, purportedly directed the Appellants not to sell aromatic tincture of cardamom.
3.6. Aggrieved by these actions, the Appellants filed Writ C No.13134 of 2022 before the High Court, seeking quashing of the impugned orders restricting their trade and an interim direction permitting them to continue their lawful business. The High Court, however, dismissed the writ petition on 12.07.2022, holding inter alia that “alcohol mixed tincture is a prohibited article,” thereby upholding the actions taken by the Respondent authorities. The Appellants filed a Civil Misc. Review Application No.355 of 2022, but the review petition was also dismissed on 22.09.2022.
3.7. The Appellants are before this Court challenging the aforesaid orders of the High Court and seek restoration of their right to carry on their business in accordance with their valid license and the statutory provisions.
4. The learned counsel for the Appellants, Shri Nikhil Goel, advanced the following arguments:
4.1. The learned counsel for the Appellants contends that the High Court erred in categorizing aromatic tincture of cardamom as a “prohibited article.” According to the Appellants, no such prohibition exists under the D&C Act, 1940, or any notification issued thereunder. Section 26A of the D&C Act, 1940 empowers only the Central Government to regulate, restrict, or prohibit the sale and distribution of any drug in the public interest. There being no notification prohibiting this particular tincture, the Respondent authorities have no jurisdiction to treat it as a banned substance.
4.2. The Appellants argue that the impugned orders passed by the Respondent authorities and the High Court’s endorsement of 2106 [2024] 12 S.C.R.Supreme Court Reports such actions infringe their fundamental right to carry on a lawful trade or business under Article 19(1)(g) of the Constitution of India. They stress that they possess a valid license and are in compliance with all applicable regulations.
4.3. The Appellants further submit that repeated inspections, arbitrary interference, and harassment by the Respondent authorities are motivated by extraneous reasons, including retaliation for complaints made against officials demanding bribes. The unlawful actions have resulted in closure of their shops, causing significant financial loss and damage to their reputation.
4.4. The Appellants emphasize that the tincture in question is a regulated drug, commonly used for minor digestive ailments, and does not figure in any list of prohibited or banned medicines. Multiple RTI responses from different governmental departments have confirmed that aromatic tincture of cardamom is a licensed medicine and does not require a doctor’s prescription. In these circumstances, the restriction placed by the Respondent authorities is wholly unjustified and arbitrary.
5. In response, the learned counsel for the Respondent Authorities, Mr. Samar Vijay Singh, urged the following contentions:
5.1. The Respondent authorities, while denying any mala fide intent, contend that aromatic cardamom tincture has extremely high alcohol content (around 84% to 87% v/v). According to them, the substance is being misused as a cheap substitute for country liquor by vulnerable sections of society, including daily-wage earners and rickshaw pullers. They argue that large quantities of this tincture are sold by the Appellants’ shop without proper records or the presence of a registered pharmacist, and no other medicines are reportedly being sold.
5.2. The Respondent authorities insist that the manner of sale and the demographics of the customers indicate that the tincture is effectively being used as an intoxicant rather than a medicinal preparation. They claim that its indiscriminate consumption poses serious health hazards and may lead to untimely deaths. They further submit that the misuse is causing substantial revenue losses to the State, as the tincture is replacing taxed country liquor.
[2024] 12 S.C.R. 2107M/s Bhagwati Medical Hall & Anr. v. Central Drugs Standard Control Organization & Ors.
Continue reading
Sign in and become a member to continue reading this judgment and every other document in the library.
Members read the full text, download where permitted, and keep notes and bookmarks.